A Single Center, Open-label, Randomized Comparative Study to Evaluate the Effect of Aliskiren on Myocardial Perfusion Reserve and Coronary Flow Reserve in Hypertensive Patients with a history of Myocardial Infarction

Trial Profile

A Single Center, Open-label, Randomized Comparative Study to Evaluate the Effect of Aliskiren on Myocardial Perfusion Reserve and Coronary Flow Reserve in Hypertensive Patients with a history of Myocardial Infarction

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 17 May 2016

At a glance

  • Drugs Aliskiren; Antihypertensives
  • Indications Cardiovascular disorders; Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 May 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 06 Oct 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 02 May 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top